American doctors have documented 84 hearing-related adverse events in patients taking teprotumumab (Tepezza) for thyroid eye disease, a treatment which...
Read moreDetailsOphthalmic device distributor BOC Instruments has received TGA registration for its new RetiCam 3100 Plus wide-field fundus camera. In a...
Read moreDetailsAlcon has revealed its “highly anticipated” Unity Vitreoretinal Cataract System and Unity Cataract System have been included on the Australian...
Read moreDetailsThe Australian Therapeutic Goods Administration (TGA) has approved Eylea 8mg, a higher dose of aflibercept for adults with neovascular aged-related...
Read moreDetailsThe Therapeutic Goods Administration (TGA) has granted Lucentis (ranibizumab) an indication for retinopathy of prematurity (ROP), making it the first...
Read moreDetailsGlaukos has secured Australian regulatory approval for the Preserflo MicroShunt, offering late-stage glaucoma patients a more elegant surgical alternative to...
Read moreDetailsIn a historical development for the eye health sector, the Therapeutics Goods Administration (TGA) has approved the country’s first true...
Read moreDetailsInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited